Search results

64 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC researchers awarded pilot grants for Zika research
UNC investigators will study diagnostics, transmission, and neurological effects of Zika, which has been reported in 62 countries and territories.
Located in News / 2016 / June
UNC’s de Silva leads expert panel on Zika research, response
Seventy-five percent of people infected with Zika don’t show any symptoms. An expert panel at RTI International delved into the issues surrounding the virus, including the lack of diagnostic tools.
Located in News / 2016 / June
HIV Treatment Keeps Uninfected Partner from Contracting the Virus
Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission according to the groundbreaking study led by Myron Cohen, MD.
Located in News / 2016 / July
Antibodies from dengue virus survivors can be used to prevent Zika infection
A joint study conducted by UNC Gillings School of Global Public Health and UNC School of Medicine shows that individuals previously infected with dengue virus could have key antibodies that protect against the Zika virus.
Located in News / 2016 / July
Training a Nation
For the past eight years, Anthony Charles, MD, has built the Malawian Surgical Initiative, training Malawian surgeons to care for their own and providing transformative educational experiences for UNC medical students and residents.
Located in News / 2016 / August
UNC scientists named to European Union-funded global Zika research consortium
The UNC School of Medicine was one of two U.S. institutions named to an international research consortium funded through the European Union’s Horizon 2020 Programme, which invested $49 million in Zika research and vaccine development at more than 20 laboratories in Europe and Brazil.
Located in News / 2016 / November
‘Unraveling Zika’: Join UNC School of Medicine experts for panel discussion, Q&A
The UNC School of Medicine has more than a dozen groups dedicated to Zika research and vaccine development. On Tuesday, Nov. 29, the School of Medicine will host an expert panel event and Q&A discussion in the Nelson Mandela Auditorium at UNC’s FedEx Global Education Center. The event is open to the public and audience questions are encouraged.
Located in News / 2016 / November
Cigar warning labels are not equally believable among adolescents
Less than 50 percent of surveyed teens found it ‘very believable’ that cigars are not a safe alternative to cigarettes, according to a first-of-its-kind UNC School of Medicine study.
Located in News / 2016 / December
Becoming Less Super as a Specialist
Dr. David Wohl, an HIV/AIDS specialist at UNC, reflects on the reasons why he now finds himself drawn to fighting Ebola.
Located in News / 2015 / January
Early Antiretroviral Therapy Protects Sero-Discordant Couples from Transmission of HIV to Their Uninfected Partner
These findings demonstrate that antiretroviral therapy, when taken until viral suppression is achieved and sustained, is a highly effective, durable intervention for HIV prevention.
Located in News / 2015 / July